HSD11B2 and medulloblastoma: Importantly, genetic ablation of HSD11B2 reduced the size of medulloblastoma in the SmoM transgenic mouse model, suggesting that HSD11β2 inhibitors might be applied as cilia-related cancer therapies (Daggubati et al., 2021).